An open-label study to evaluate the effect of a loading dose followed by a maintenance dose of Bondronat [ibandronic acid] on pain relief in patients with bone pain secondary to metastatic bone disease.

Trial Profile

An open-label study to evaluate the effect of a loading dose followed by a maintenance dose of Bondronat [ibandronic acid] on pain relief in patients with bone pain secondary to metastatic bone disease.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Feb 2010

At a glance

  • Drugs Ibandronic acid (Primary)
  • Indications Cancer; Cancer metastases
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 16 Apr 2008 Status changed from in progress to completed.
    • 24 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top